Reproducibility of high-resolution MRI for the middle cerebral artery plaque at 3 T

https://doi.org/10.1016/j.ejrad.2013.10.003Get rights and content

Abstract

Purpose

To assess the reproducibility of HR-MRI for the identification of MCA atherosclerotic plaque components and quantification of stenosis.

Materials and methods

Seventy-three consecutive subjects who initially had ischemic stroke or asymptomatic MCA stenosis (>50%) were enrolled in the study. All subjects were scanned using 3.0 T MRI. Two independent readers reviewed all images and one reader reevaluated all images four weeks later. The tissue components of plaques were analyzed qualitatively and the vessels were quantitative measured.

Results

HR-MRI displayed the artery wall and lumen clearly. The intra-observer reproducibility was excellent for the identification of plaques (kappa [κ] = 0.96; 95% CI: 0.83–1.04) and contrast enhancement (κ = 0.89; 0.78–0.95); it was substantial for intra-plaque hemorrhage (κ = 0.79; 0.57–0.96) and the fibrous cap (κ = 0.65; 0.42–0.86). The inter-observer reproducibility was excellent for plaques (κ = 0.92; 0.73–1.06), substantial for contrast enhancement (κ = 0.80; 0.65–0.93), intra-plaque hemorrhage (κ = 0.68; 0.47–0.92) and moderate for the fibrous cap (κ = 0.58; 0.44–0.79). Both intra-observer and inter-observer reproducibility were excellent for quantitative vessel, lumen and wall measurements with intraclass correlation coefficients ranging from 0.91 to 0.97 and 0.87 to 0.96, respectively. However, vessel and wall areas and the intervals defined by the Bland–Altman plots were wide in comparison to the mean.

Conclusions

The identification of MCA atherosclerotic plaque components and the quantification of vessel and lumen measurements are reproducible. The reproducibility is overall acceptable. HR-MRI may provide a useful tool for clinical risk evaluation in MCA atherosclerosis.

Introduction

Intracranial large-artery atherosclerotic stroke, especially in the middle cerebral artery (MCA), is a common cause of ischemic stroke in African, Asian, and Hispanic populations. In Chinese populations, estimates of the responsibility of intracranial stenosis in causing stroke are about 33–50% [1]. Digital subtraction angiography (DSA), CT angiography (CTA) and MR angiography (MRA) are the most commonly used tools to detect intracranial artery atherosclerotic stenosis. However, these imaging modalities only show luminal narrowing and fail to show vascular wall characterization. Reports have shown that the risk of ischemic stroke is predicted more by plaque components than by the degree of luminal narrowing [2], [3]. In recent years, many high-resolution-MRI (HR-MRI) studies have been used to depict the MCA wall and lumen, identify arterial atherosclerotic plaques, dissection and vasculitis [4], explore the plaque distribution characteristics and the remodeling [5], [6], and help with understanding atherosclerosis pathophysiology [7], [8], [9]. In measuring atherosclerosis burden and plaque instability, HR-MRI can be a potential guide for identification of high-risk patients requiring more intensive treatments; it can also be used to monitor the effect of treatments [10]. These previous studies usually focused on case report and small samples. Reproducibility of HR-MRI for the identification of different MCA plaque components and lumen measurements has rarely been addressed. Furthermore, comparative studies between MCA imaging and pathology findings are very difficult to conduct. Hence, it has practical significance to evaluate the reproducibility of in vivo MRI for the recognition and quantitative measurements of MCA atherosclerotic plaque.

The purpose of this study was to assess the intra-and inter-observer reproducibility of high-resolution MRI for the identification and quantification of MCA atherosclerotic plaque and stenosis and to compare the difference of plaque characterization and vessel wall properties between symptomatic and asymptomatic atherosclerotic MCA using this technique. We hypothesized that the identification of MCA plaque components and the quantification of vessel using HR-MRI are reproducible. The reproducibility is overall acceptable during clinical practice and for further research.

Section snippets

Subjects

High-resolution MRI in atherosclerotic stenosis of the MCA was partial of an ongoing multicenter prospective study analyzing the multimoding diagnosis of acute ischemic stroke and assessing the prognostic value. Patients with the following features were included: (1) MCA stenosis ≥50% at the M1 segment on conventional angiography; (2) without any other major cause of stroke; and (3) ≥2 risk factors (hypertension, diabetes mellitus, hyperlipidemia, cigarette smoking, and obesity) for

Results

Between March 2010 and February 2013, seventy-three subjects (46 males and 27 females) were enrolled in the study. Median age of the subjects was 64 years (range: 30–84 years). Among them 38 had a stroke, 3 had a transient ischemic attack and 32 were asymptomatic. The median time from stroke onset to MRI examination in symptomatic patients was 10 days (range, 4–17).

A total of 65 plaques were found on HR-MRI. Plaques were found in each of the 41 symptomatic cases (41/41) and 24 of the

Discussion

Our study demonstrates the capability of in vivo HR-MRI to delineate MCA wall structure. In our study, inter- and intra-observer agreements were excellent for the identification of plaques and substantial to excellent for contrast enhancement. As expected, intra-observer reproducibility was better than inter-observer reproducibility. The results were similar to those observed in previous studies. Li et al. analyzed 49 MCAs of 48 patients and found both intra-observer and inter-observer

Conclusions

Feasibility and reproducibility of HR-MRI for identifying MCA atherosclerotic plaque components is generally acceptable. Plaque characterization and vessel wall properties on HR-MRI were different between symptomatic and asymptomatic MCA stenosis. The presence of vulnerable plaque is closely related to stroke. Hence, HR-MRI may provide a useful tool for clinical risk evaluation in MCA atherosclerosis.

Conflict of interest

There is no conflict of interest statement.

Acknowledgements

This work was partially supported by Chinese National 12th Five-year Science and Technology Supporting Program under grant 2011BAI08B10, National Natural Science Foundation of China under grant 81271560 and Medical Scientific Research Foundation of Guangdong Province under grant A2012011.

References (25)

  • B. Huang et al.

    Basilar artery atherosclerotic plaques distribution in symptomatic patients: a 3.0 T high-resolution MRI study

    Eur J Radiol

    (2013)
  • C.W. Ryu et al.

    High resolution wall and lumen MRI of the middle cerebral arteries at 3 tesla

    Cerebrovasc Dis

    (2009)
  • Cited by (48)

    • MR Vessel Wall Imaging for Atherosclerosis and Vasculitis

      2024, Neuroimaging Clinics of North America
    • Vessel wall magnetic resonance imaging of symptomatic middle cerebral artery atherosclerosis: A systematic review and meta-analysis

      2022, Clinical Imaging
      Citation Excerpt :

      The 17 included studies were all based on the Asian population: 16 were from China11,13,21,25–37 and one from South Korea.38 Eight11,21,25–27,30,37,38 and nine13,28,29,31–36 studies were prospective and retrospective cross-sectional studies, respectively. In all the included studies, VWI was performed on 3.0 Tesla scanner using different types of coils.

    • Height is Inversely Associated with Biomarkers of Intracranial Atherosclerotic Disease in Older Adults of Amerindian Ancestry: Exploring the Obesity Paradox

      2022, Journal of Stroke and Cerebrovascular Diseases
      Citation Excerpt :

      Ethnic disparities in the incidence of ICAD are not fully understood. It has been argued that competing etiologies such as Moyamoya disease, arterial dissections and vasculitis may partly account for the higher prevalence of ICAD (when compared with extracranial atherosclerosis) reported in Asian studies.40 Despite this potential overestimation, recent reviews disclosed robust evidence supporting the ethnic differences in ICAD burden.33,34

    View all citing articles on Scopus
    View full text